Remove 2019 Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

The History and Noble Purpose of the 340B Drug Pricing Program

Omnicell

Census Bureau announced that the number of Americans in poverty in 2019 was 34 million, about 10.5 Growth of the Program Over the years, the 340B program has experienced significant growth, with more than 2,500 hospitals participating in the program in 2019, in partnership with over 25,000 contract pharmacies that same year.

article thumbnail

From agility to AI: Safeguarding against supply chain disruptions

Pharmaceutical Technology

Goods were largely delivered on time, and at a low cost, benefitting both companies and consumers. According to GlobalData’s Social Media Analytics, supply chains were mentioned on Reddit and Twitter 1,908 times in 2019. Any reduced availability of medicines has a significant impact on patient care. The tech solution.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

PQA Welcomes 11 New Members

PQA

The platform is being used by leading healthcare organizations to achieve significant ROI, improve health outcomes, attain the highest quality ratings, and reduce cost of care. Strong relationships mean coordinated care, more time on what matters most, information sharing, trust, understanding.

article thumbnail

PQA Welcomes 11 New Members

PQA

The platform is being used by leading healthcare organizations to achieve significant ROI, improve health outcomes, attain the highest quality ratings, and reduce cost of care. Strong relationships mean coordinated care, more time on what matters most, information sharing, trust, understanding.

article thumbnail

Preparing for a post-pandemic world

pharmaphorum

Many patients and healthcare providers now meet online, and some clinical studies can be conducted virtually, with wearables and AI enabling data collection and treatment adaptation. The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

Telemedicine rose dramatically in many countries, providing a route to managing ongoing care which was a lifeline for many patients. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. Launches, therefore, were happening. But were they fulfilling their commercial potential?